Tyrosine kinase inhibitors (TKIs) are targeted therapy drugs that block enzymes called tyrosine kinases, which play key roles in cancer cell signaling and growth. TKIs are effective against various cancers, including lung, kidney, and gastrointestinal stromal tumors. Treatment requires molecular testing to identify suitable patients. Side effects may include rash, diarrhea, and fatigue, requiring ongoing management by oncology specialists to optimize therapy.
2025 Bangkok Prices
TKI Therapy: THB 150,000–650,000 per treatment cycle depending on specific drug
Includes molecular profiling, drug administration, and adverse event monitoring
Available at leading cancer centers with advanced precision oncology programs.